Literature DB >> 23052745

Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.

Kiyomi Horiuchi1, Takahiro Okamoto, Masatoshi Iihara, Toshihiko Tsukada.   

Abstract

PURPOSE: To examine the clinical characteristics and survival outcomes of patients with primary hyperparathyroidism (PHPT) in multiple endocrine neoplasia type 1 (MEN1) in relation to the MEN1 gene mutation.
METHODS: The study population included the patients, positive for the MEN1 gene mutation, who underwent parathyroidectomy between 1983 and 2009 at a single tertiary referral center. Manifestations of the syndrome, other tumors and causes of death were retrospectively correlated with the specific types and locations of MEN1 gene mutations.
RESULTS: Thirty-two patients from 19 families were diagnosed as having MEN1 on genetic examinations. Mutations were most common in exons 2, 7 and 10. A phenotypic analysis of the main MEN1 tumor types among the 32 patients revealed that PHPT was the most common (100 %), followed in order by pancreatic neuroendocrine tumors (PNETs) (53 %) and pituitary tumors (38 %). Death due to MEN1-related disease occurred in five patients (16 %), including malignant PNET in three cases (exons 2, 3), pituitary crisis in one case (exon 2) and thymic cancer in one case (large deletion).
CONCLUSIONS: Premature deaths related to MEN1 are due to the development of malignant PNET, pituitary crisis or thymic tumors associated with mutations in exons 2, 3 and a large deletion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052745     DOI: 10.1007/s00595-012-0354-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

1.  Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved.

Authors:  L O UNDERDAHL; L B WOOLNER; B M BLACK
Journal:  J Clin Endocrinol Metab       Date:  1953-01       Impact factor: 5.958

2.  Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.

Authors:  P Ferolla; A Falchetti; P Filosso; P Tomassetti; G Tamburrano; N Avenia; G Daddi; F Puma; R Ribacchi; F Santeusanio; G Angeletti; M L Brandi
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

3.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

4.  Lethality of multiple endocrine neoplasia type I.

Authors:  G M Doherty; J A Olson; M M Frisella; T C Lairmore; S A Wells; J A Norton
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

5.  Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1).

Authors:  N Hai; N Aoki; A Matsuda; T Mori; S Kosugi
Journal:  Eur J Endocrinol       Date:  1999-11       Impact factor: 6.664

Review 6.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

7.  Genotype-phenotype analysis in multiple endocrine neoplasia type 1.

Authors:  Maria A Kouvaraki; Jeffrey E Lee; Suzanne E Shapiro; Robert F Gagel; Steven I Sherman; Rena V Sellin; Gilbert J Cote; Douglas B Evans
Journal:  Arch Surg       Date:  2002-06

8.  Are patients with multiple endocrine neoplasia type I prone to premature death?

Authors:  P G Dean; J A van Heerden; D R Farley; G B Thompson; C S Grant; W S Harmsen; D M Ilstrup
Journal:  World J Surg       Date:  2000-11       Impact factor: 3.352

9.  Cause of death in multiple endocrine neoplasia type 1.

Authors:  S Wilkinson; B T Teh; K R Davey; J P McArdle; M Young; J J Shepherd
Journal:  Arch Surg       Date:  1993-06

Review 10.  Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

View more
  3 in total

1.  Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients.

Authors:  Minerva Angélica Romero Arenas; Richard G Fowler; F Anthony San Lucas; Jie Shen; Thereasa A Rich; Elizabeth G Grubbs; Jeffrey E Lee; Paul Scheet; Nancy D Perrier; Hua Zhao
Journal:  Surgery       Date:  2014-11-11       Impact factor: 3.982

2.  Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China.

Authors:  Yuan Zhao; Jie Yu; Yiwen Liu; Lu Lyu; Fan Ping; Lingling Xu; Wei Li; Ou Wang; Qiang Xu; Wenming Wu; Huabing Zhang; Yuxiu Li
Journal:  Orphanet J Rare Dis       Date:  2022-06-13       Impact factor: 4.303

3.  Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome.

Authors:  Elizaveta Mamedova; Natalya Mokrysheva; Evgeny Vasilyev; Vasily Petrov; Ekaterina Pigarova; Sergey Kuznetsov; Nikolay Kuznetsov; Liudmila Rozhinskaya; Galina Melnichenko; Ivan Dedov; Anatoly Tiulpakov
Journal:  Endocr Connect       Date:  2017-09-04       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.